Improvement of Tolerability and Adverse Events Occurrence during Treatment with Dasatinib Used on a Compassionate Basis in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) / Martino B; Rege Cambrin G; Gozzini A; Stagno F; Brecci M; Specchia G; Orlandi E; Pungolino E; Falzetti F; Galimberti S; Fava C; Marino A; Nobile F.. - In: BLOOD. - ISSN 0006-4971. - 110(2007), pp. 4564-4564.
Titolo: | Improvement of Tolerability and Adverse Events Occurrence during Treatment with Dasatinib Used on a Compassionate Basis in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP). |
Autori interni: | |
Anno del prodotto: | 2007 |
Rivista: | BLOOD |
Handle: | http://hdl.handle.net/11568/116272 |
Appare nelle tipologie: | 1.5 Abstract in rivista |
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.